Corpus Intelligence IC Memo — SSH - CINCINNATI INC. 2026-04-26 18:03 UTC
IC Memo — SSH - CINCINNATI INC.
Investment Committee Memorandum | OH | 71 beds | Grade C | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - CINCINNATI INC.

CCN 362019 | HAMILTON, OH | 71 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSH - CINCINNATI INC. is a 71-bed suburban community hospital in HAMILTON, OH with $39.1M in net patient revenue and a 12.6% operating margin. The hospital serves a payer mix of 27.4% Medicare, 9.5% Medicaid, and 63.1% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.6% to 20.0% (+736bps).

Net Revenue HCRIS$39.1M
Current EBITDA COMPUTED$4.9M
Operating Margin COMPUTED12.6%
Occupancy HCRIS70.0%
Revenue / Bed COMPUTED$551K
Net-to-Gross HCRIS12.4%
Distress Probability ML43.8%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
93
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 12.6% places it above the state median. Among 93 size-comparable peers (36-142 beds), the median margin is 1.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-142), prioritizing same-state peers. 93 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - CINCINNATI INC. (Target)OH71$39.1M12.6%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
SOIN MEDICAL CENTEROH120$256.3M-1.3%
LIMA MEMORIAL HOSPITALOH110$253.5M6.4%
UH ST. JOHN MEDICAL CENTEROH126$210.9M6.5%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
ST. JOSEPH HEALTH CENTEROH135$194.2M5.8%
UH GEAUGA MEDICAL CENTEROH106$183.3M6.9%
CLEVELAND CLINIC AVON HOSPITALOH126$178.3M16.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$822K+210bp18mo
Cost to Collect4.5%2.5%$783K+200bp12mo
Denial Rate Reduction12.0%6.5%$775K+198bp12mo
A/R Days Reduction5200.0%3800.0%$476K+122bp9mo
Clean Claim Rate88.0%96.0%$25K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$822K
Cost to Collect
$783K
Denial Rate Reduction
$775K
A/R Days Reduction
$476K
Clean Claim Rate
$25K
Total EBITDA Uplift$2.9M
Current EBITDA$4.9M
+ RCM Uplift+$2.9M
Pro Forma EBITDA$7.8M
Current Margin12.6%
Pro Forma Margin20.0%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.6M$61.4M8.08x51.9%
Base (11x exit)10.0x11.0x$7.6M$70.0M9.21x55.9%
Bull Case9.0x11.0x$6.8M$82.0M11.98x64.3%
Bull (12x exit)9.0x12.0x$6.8M$91.5M13.37x68.0%
Bear Case11.0x10.0x$8.4M$44.5M5.32x39.7%
Bear (11x exit)11.0x11.0x$8.4M$51.7M6.18x44.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 93 hospitals with 36-142 beds
  • Same-state prioritization (n=94)
  • Comp margins: P25=-14.0% / P50=1.4% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.